Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter Mu-Hsin Chang

Showing results (31-40 of 93) with videos related to

Pageof 10
Sort By:
Cell Communication and Signaling : CCS|October 22, 2020
Kinase shRNA screening reveals that TAOK3 enhances microtubule-targeted drug resistance of breast cancer cells via the NF-κB signaling pathwayTsung-Ching Lai, Chih-Yeu Fang, Yi-Hua Jan, et al.
Journal of Vascular Surgery|August 21, 2013
Predisposing factors, management, and prognostic evaluation of acute carotid blowout syndromeHsueh-Ju Lu, Kuo-Wei Chen, Ming-Huang Chen, et al.
Oral Oncology|July 8, 2014
Neck observation is appropriate in T1-2, cN0 oral squamous cell carcinoma without perineural invasion or lymphovascular invasionChien-Fu Yeh, Wing-Yin Li, Muh-Hwa Yang, et al.
Japanese Journal of Clinical Oncology|March 28, 2013
Serum albumin is an important prognostic factor for carotid blowout syndromeHsueh-Ju Lu, Kuo-Wei Chen, Ming-Huang Chen, et al.
Annals of Surgical Oncology|December 29, 2011
Treatment for T1-2 oral squamous cell carcinoma with or without perineural invasion: neck dissection and postoperative adjuvant therapyShyh-Kuan Tai, Wing-Yin Li, Muh-Hwa Yang, et al.
Journal of the Chinese Medical Association : JCMA|July 7, 2010
Cetuximab-based therapy in recurrent/metastatic head and neck squamous cell carcinoma: experience from an area in which betel nut chewing is popularPeter Mu-Hsin Chang, Yao-Yu Hsieh, Ming-Huang Chen, et al.
Biomed Research International|March 21, 2015
Modified weekly cisplatin-based chemotherapy is acceptable in postoperative concurrent chemoradiotherapy for locally advanced head and neck cancerHsueh-Ju Lu, Chao-Chun Yang, Ling-Wei Wang, et al.
In Vivo (Athens, Greece)|June 27, 2024
Paclitaxel-Ifosfamide-based Therapy as Salvage Treatment in Platinum-resistant Recurrent/Metastatic Head and Neck CancerMing-Yu Chou, Wen-Chi Wu, Pen-Yuan Chu, et al.
Journal of the Chinese Medical Association : JCMA|November 22, 2011
Pretreatment risk stratification for non-metastatic head and neck squamous cell carcinoma in a high-prevalence areaYao-Yu Hsieh, Peter Mu-Hsin Chang, Ming-Huang Chen, et al.
Frontiers in Oncology|August 1, 2022
Dehydroepiandrosterone (DHEA) Sensitizes Irinotecan to Suppress Head and Neck Cancer Stem-Like Cells by Downregulation of WNT SignalingLi-Jie Li, Chien-Hsiu Li, Peter Mu-Hsin Chang, et al.
Pageof 10

Showing results (31-40 of 93) with videos related to

Sort By:
Pageof 10
Cell Communication and Signaling : CCS|October 22, 2020
Kinase shRNA screening reveals that TAOK3 enhances microtubule-targeted drug resistance of breast cancer cells via the NF-κB signaling pathwayTsung-Ching Lai, Chih-Yeu Fang, Yi-Hua Jan, et al.
Journal of Vascular Surgery|August 21, 2013
Predisposing factors, management, and prognostic evaluation of acute carotid blowout syndromeHsueh-Ju Lu, Kuo-Wei Chen, Ming-Huang Chen, et al.
Oral Oncology|July 8, 2014
Neck observation is appropriate in T1-2, cN0 oral squamous cell carcinoma without perineural invasion or lymphovascular invasionChien-Fu Yeh, Wing-Yin Li, Muh-Hwa Yang, et al.
Japanese Journal of Clinical Oncology|March 28, 2013
Serum albumin is an important prognostic factor for carotid blowout syndromeHsueh-Ju Lu, Kuo-Wei Chen, Ming-Huang Chen, et al.
Annals of Surgical Oncology|December 29, 2011
Treatment for T1-2 oral squamous cell carcinoma with or without perineural invasion: neck dissection and postoperative adjuvant therapyShyh-Kuan Tai, Wing-Yin Li, Muh-Hwa Yang, et al.
Journal of the Chinese Medical Association : JCMA|July 7, 2010
Cetuximab-based therapy in recurrent/metastatic head and neck squamous cell carcinoma: experience from an area in which betel nut chewing is popularPeter Mu-Hsin Chang, Yao-Yu Hsieh, Ming-Huang Chen, et al.
Biomed Research International|March 21, 2015
Modified weekly cisplatin-based chemotherapy is acceptable in postoperative concurrent chemoradiotherapy for locally advanced head and neck cancerHsueh-Ju Lu, Chao-Chun Yang, Ling-Wei Wang, et al.
In Vivo (Athens, Greece)|June 27, 2024
Paclitaxel-Ifosfamide-based Therapy as Salvage Treatment in Platinum-resistant Recurrent/Metastatic Head and Neck CancerMing-Yu Chou, Wen-Chi Wu, Pen-Yuan Chu, et al.
Journal of the Chinese Medical Association : JCMA|November 22, 2011
Pretreatment risk stratification for non-metastatic head and neck squamous cell carcinoma in a high-prevalence areaYao-Yu Hsieh, Peter Mu-Hsin Chang, Ming-Huang Chen, et al.
Frontiers in Oncology|August 1, 2022
Dehydroepiandrosterone (DHEA) Sensitizes Irinotecan to Suppress Head and Neck Cancer Stem-Like Cells by Downregulation of WNT SignalingLi-Jie Li, Chien-Hsiu Li, Peter Mu-Hsin Chang, et al.
Pageof 10